PHARMACEUTICAL COMPOSITION FOR TREATING CANCER, CONTAINING LACTATE METAL SALT

USPTO Patent Application US 2017/0360727 A1
Application Date: Dec. 21st, 2017

ABSTRACT

The present invention relates to: a pharmaceutical composition for treating cancer containing, as an active ingredient, a metal lactate salt, which can be dissociated, in cancer cells, into lactate capable...
Application Number:
15/629,445
International Classification:
A61K 31/19 (20060101); A23L 33/16 (20060101); A23L 33/00 (20060101); A61K 39/395 (20060101); A61K 31/555 (20060101); A61K 31/5377 (20060101); A61K 31/519 (20060101); A61K 31/517 (20060101); A61K 31/513 (20060101); A61K 31/506 (20060101); A61K 31/4745 (20060101); A61K 31/44 (20060101); A61K 31/436 (20060101); A61K 31/404 (20060101); A61K 31/337 (20060101); A61K 9/00 (20060101); A61N 5/10 (20060101)
No Pictures Available

CLAIMS

What is claimed is:

1-20. (canceled)

DESCRIPTION

TECHNICAL FIELD

The present disclosure relates to a pharmaceutical composition for treating cancer including metal lactate salts, and more particularly, to a pharmaceutical composition for treating cancer including, as active ingredients, metal lactate salts capable of dissociating lactate, which can disturb metabolism of cancer cells and thus effectively inhibit activities such as...
Back to Top